drug

PRIME

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by University of California Riverside at C.I. Trials, Inc.-Inland Empire
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Investigational (via trials)
SchizophreniaSchizophrenia

Trials

1
Enhancing Motivation in Recent Onset Schizophrenia
NCT01817387—Terminated

KOLs & investigators

1
Danielle A Schlosser, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
trial
Enhancing Motivation in Recent Onset Schizophrenia
NA
trial
indication
Schizophrenia
indication
Schizophrenia
indication
KOL
Danielle A Schlosser, PhD
KOL score —
person